ActCode |
Lvl |
Type, Domain name and/or Mnemonic code |
Concept ID |
Mnemonic |
Print Name |
Definition/Description |
1
|
A: ExternallyDefinedActCodes |
16493 |
|
|
|
2
|
A: DocumentSectionType |
10871 |
|
|
The type of document section. Possible values: review of systems, medical history, family history, microscopic findings,
etc.
|
2
|
A: DocumentType |
10870 |
|
|
The kind of document. Possible values: discharge summary, progress note, Oncology note, etc. |
1
|
A: HL7DefinedActCodes |
13954 |
|
|
Domain provides the root for HL7-defined detailed or rich codes for the Act classes. |
2
|
A: AccountType |
14809 |
|
|
|
3
|
A: CreditCard |
14811 |
|
|
|
4
|
L: (AE)
|
14814 |
AE |
American Express |
|
4
|
L: (DN)
|
14815 |
DN |
Diner's Club |
|
4
|
L: (DV)
|
14816 |
DV |
Discover Card |
|
4
|
L: (MC)
|
14813 |
MC |
Master Card |
|
4
|
L: (V)
|
14812 |
V |
Visa |
|
3
|
L: (CASH)
|
14810 |
CASH |
Cash |
|
2
|
A: ActAlertCode |
16124 |
|
|
Identifies types of alerts for Act class "ALRT" |
3
|
A: ActSuppliedItemAlertCode |
16656 |
|
|
Identifies types of alerts regarding the administration or supply of an item to a patient. |
4
|
A: AdministrationAlertCode |
16657 |
|
|
Administration of the proposed therapy may be inappropriate or contraindicated as proposed |
5
|
S: ComplianceAlertCode (COMPLY)
|
16687 |
COMPLY |
Compliance Alert |
There may be an issue with the patient complying with the intentions of the proposed therapy |
6
|
L: (DUPTHPY)
|
16688 |
DUPTHPY |
Duplicate Therapy Alert |
The proposed drug therapy appears to duplicate an existing therapy |
6
|
L: (PLYDOC)
|
16689 |
PLYDOC |
Poly-orderer Alert |
A similar or identical drug therapy was recently ordered by a different provider. |
6
|
L: (PLYPHRM)
|
16690 |
PLYPHRM |
Poly-supplier Alert |
This patient was recently supplied a similar or identical drug therapy from a different supplier |
5
|
S: DosageProblemAlertCode (DOSE)
|
16680 |
DOSE |
Dosage problem |
Proposed dosage instructions for drug therapy are sub-optimal or may cause patient-injury |
6
|
S: DoseDurationAlertCode (DOSEDUR)
|
16684 |
DOSEDUR |
Dose-Duration Alert |
Proposed length of drug therapy differs from the recommended practice |
7
|
L: (DOSEDURH)
|
16686 |
DOSEDURH |
Dose-Duration High Alert |
Proposed length of drug therapy is longer than recommended |
7
|
L: (DOSEDURL)
|
16685 |
DOSEDURL |
Dose-Duration Low Alert |
Proposed length of drug therapy is shorter than that necessary for therapeutic effect |
6
|
L: (DOSEH)
|
16681 |
DOSEH |
High Dose Alert |
Proposed dosage exceeds recommended levels |
6
|
L: (DOSEIVL)
|
16683 |
DOSEIVL |
Dose-Interval Alert |
Proposed dosage interval/timing differs from the recommended practice |
6
|
L: (DOSEL)
|
16682 |
DOSEL |
Low Dose Alert |
Proposed dosage is below suggested therapeutic levels |
5
|
A: DrugAppropriatenessAlertCode |
16658 |
|
|
Drug choice may be inappropriate or contraindicated as proposed |
6
|
A: DrugInteractionAlertCode |
16659 |
|
|
Proposed drug therapy may interact with products that the patient may be or is taking |
7
|
L: (DALCH)
|
16663 |
DALCH |
Drug-Alcohol Interaction |
Proposed drug therapy may interact with alcohol |
7
|
L: (DDRG)
|
16660 |
DDRG |
Drug-Drug Interaction Alert |
Proposed drug therapy may interact with existing or recent drug therapy |
7
|
L: (DFOOD)
|
16662 |
DFOOD |
Drug-Food Interaction Alert |
Proposed drug therapy may interact with certain foods |
7
|
L: (DHERB)
|
16661 |
DHERB |
Drug-Herbal Interaction Alert |
Proposed drug therapy may interact with existing or recent herbal therapy |
6
|
S: DrugObservationAlertCode (DOBS)
|
16664 |
DOBS |
Drug-Observation Alert |
Proposed drug therapy may be inappropriate or contraindicated due to conditions or characteristics of the patient |
7
|
S: DrugConditionAlertCode (DCOND)
|
16665 |
DCOND |
Drug-Condition Alert |
Proposed drug therapy may be inappropriate or contraindicated due to an existing/recent patient condition or diagnosis |
8
|
L: (DLACT)
|
16667 |
DLACT |
Drug-Lactation Alert |
Proposed drug therapy may be inappropriate or contraindicated when breast-feeding |
8
|
L: (DPREG)
|
16666 |
DPREG |
Drug-Pregnancy Alert |
Proposed drug therapy may be inappropriate or contraindicated during pregnancy |
7
|
S: DrugReactionAlertCode (DREACT)
|
16672 |
DREACT |
Drug-Reaction Alert |
Proposed drug therapy may be inappropriate or contraindicated based on the potential for a patient reaction to the proposed
drug
|
8
|
L: (DADR)
|
16675 |
DADR |
Drug-Prior Reaction Alert |
Proposed therapy may be inappropriate or contraindicated because of a recorded prior adverse reaction to the proposed drug |
8
|
L: (DALGY)
|
16674 |
DALGY |
Drug-Allergy Alert |
Proposed drug therapy may be inappropriate or contraindicated because of a recorded patient allergy to the proposed drug.
(Allergies are immune based reactions.)
|
8
|
L: (DINT)
|
16673 |
DINT |
Drug-Intolerance Alert |
Proposed drug therapy may be inappropriate or contraindicated because of a recorded patient intolerance to the proposed drug.
(Intolerances are non-immune based sensitivities.)
|
7
|
S: RelatedDrugReactionAlertCode (RDREACT)
|
16676 |
RDREACT |
Related Drug-Reaction Alert |
Proposed drug therapy may be inappropriate or contraindicated because of a potential patient reaction to a related drug |
8
|
L: (RDADR)
|
16679 |
RDADR |
Related Drug-Prior Reaction Alert |
Proposed therapy may be inappropriate or contraindicated because of a recorded prior adverse reaction to a related drug |
8
|
L: (RDALGY)
|
16678 |
RDALGY |
Related Drug-Allergy Alert |
Proposed drug therapy may be inappropriate or contraindicated because of a recorded patient allergy to a related drug. (Allergies
are immune based reactions.)
|
8
|
L: (RDINT)
|
16677 |
RDINT |
Related Drug-Intolerance Alert |
Proposed drug therapy may be inappropriate or contraindicated because of a recorded patient intolerance to a related drug.
(Intolerances are non-immune based sensitivities.)
|
7
|
L: (DAGE)
|
16669 |
DAGE |
Drug-Age Alert |
Proposed drug therapy may be inappropriate or contraindicated due to patient age |
7
|
L: (DGEN)
|
16671 |
DGEN |
Drug-Genetic Alert |
Proposed drug therapy may be inappropriate or contraindicated due to patient genetic indicators |
7
|
L: (DGEND)
|
16670 |
DGEND |
Drug-Gender Alert |
Proposed drug therapy may be inappropriate or contraindicated due to patient gender |
7
|
L: (DLAB)
|
16668 |
DLAB |
Drug-Lab Alert |
Proposed drug therapy may be inappropriate or contraindicated due to recent lab test result |
4
|
A: SupplyAlertCode |
16691 |
|
|
Supplying of the drug at this time may be inappropriate or indicate a compliance issues with the associated drug therapy |
5
|
L: (TOOLATE)
|
16693 |
TOOLATE |
Refill Too Late Alert |
This patient is receiving a second fill significantly later than would be expected based on amount previously supplied combined
with therapy dosage instructions
|
5
|
L: (TOOSOON)
|
16692 |
TOOSOON |
Refill Too Soon Alert |
This patient is receiving a second fill significantly earlier than would be expected based on amount previously supplied combined
with therapy dosage instructions
|
2
|
A: ActAlertManagementCode |
16695 |
|
|
Codes dealing with the management of Alert observations |
3
|
S: OtherActionTakenManagementCode (08)
|
16703 |
08 |
Other action taken |
Order is performed as issued, but other action taken to mitigate potential adverse effects |
4
|
L: (09)
|
16704 |
09 |
Instituted ongoing monitoring program |
Arranged to monitor patient for adverse effects |
4
|
L: (10)
|
16705 |
10 |
Provided patient education |
Provided education or training to the patient on appropriate therapy use |
4
|
L: (11)
|
16706 |
11 |
Added concurrent therapy |
Instituted an additional therapy to mitigate potential negative effects |
4
|
L: (12)
|
16707 |
12 |
Temporarily suspended concurrent therapy |
Suspended existing therapy that triggered interaction for the duration of this therapy |
4
|
L: (13)
|
16708 |
13 |
Stopped concurrent therapy |
Aborted existing therapy that triggered interaction. |
3
|
S: SupplyAppropriateManagementCode (14)
|
16709 |
14 |
Supply Appropriate |
Confirmed supply action appropriate |
4
|
L: (15)
|
16710 |
15 |
Replacement |
Patient's existing supply was lost/wasted |
4
|
L: (16)
|
16711 |
16 |
Vacation supply |
Supply date is due to patient vacation |
4
|
L: (17)
|
16712 |
17 |
Weekend Supply |
Supply date is intended to carry patient over weekend |
3
|
S: TherapyAppropriateManagementCode (01)
|
16696 |
01 |
Therapy Appropriate |
Confirmed drug therapy appropriate |
4
|
S: ConsultedPrescriberManagementCode (05)
|
16700 |
05 |
Consulted Prescriber |
Consulted prescriber, therapy confirmed |
5
|
L: (06)
|
16701 |
06 |
Prescriber Declined Change |
Consulted prescriber and recommended change, prescriber declined |
4
|
L: (02)
|
16697 |
02 |
Assessed Patient |
Assessed patient, therapy is appropriate |
4
|
L: (03)
|
16698 |
03 |
Patient Explanation |
Patient gave adequate explanation |
4
|
L: (04)
|
16699 |
04 |
Consulted Other Source |
Consulted other supply source, therapy still appropriate |
4
|
L: (07)
|
16702 |
07 |
Interacting therapy no longer active/planned |
Concurrent therapy triggering alert is no longer on-going or planned |
2
|
A: ActContainerRegistrationCode |
14058 |
|
|
Constrains the ActCode to the domain of Container Registration |
3
|
L: (I)
|
14059 |
I |
Identified |
used by one system to inform another that it has received a container |
3
|
L: (L)
|
14063 |
L |
Left Equipment |
used by one system to inform another that the container has been released from that system. |
3
|
L: (M)
|
14064 |
M |
Missing |
used by one system to inform another that the container did not arrive at its next expected location. |
3
|
L: (O)
|
14061 |
O |
In Process |
used by one system to inform another that the specific container is being processed by the equipment. It is useful as a response
to a query about Container Status, when the specific step of the process is not relevant.
|
3
|
L: (P)
|
14060 |
P |
In Position |
used by one system to inform another that the container is in position for specimen transfer (e.g., container removal from
track, pipetting, etc.).
|
3
|
L: (R)
|
14062 |
R |
Process Completed |
status is used by one system to inform another that the processing has been completed, but the container has not been released
from that system.
|
3
|
L: (X)
|
14065 |
X |
Container Unavailable |
used by one system to inform another that the container is no longer available within the scope of the system (e.g., tube
broken or discarded).
|
2
|
A: ActDietCode |
10376 |
|
|
Code set to define specialized/allowed diets |
3
|
L: (BR)
|
10379 |
BR |
breikost (GE) |
A diet exclusively composed of oatmeal, semolina, or rice, to be extremely easy to eat and digest. |
3
|
L: (DM)
|
10383 |
DM |
diabetes mellitus diet |
A diet that uses carbohydrates sparingly. Typically with a restriction in daily energy content (e.g. 1600o2000 kcal.) |
3
|
L: (FAST)
|
10382 |
FAST |
fasting |
No enteral intake of foot or liquids whatsoever, no smoking. Typically 6 to 8 hours before anesthesia. |
3
|
L: (GF)
|
10390 |
GF |
gluten free |
Gluten free diet for celiac disease. |
3
|
L: (LF)
|
10386 |
LF |
low fat |
A diet low in fat, particularly to patients with hepatic diseases. |
3
|
L: (LP)
|
10389 |
LP |
low protein |
A low protein diet for patients with renal failure. |
3
|
L: (LQ)
|
10380 |
LQ |
liquid |
A strictly liquid diet, that can be fully absorbed in the intestine, and therefore may not contain fiber. Used before enteral
surgeries.
|
3
|
L: (LS)
|
10388 |
LS |
low sodium |
A diet low in sodium for patients with congestive heart failure and/or renal failure. |
3
|
L: (N)
|
10377 |
N |
normal diet |
A normal diet, i.e. no special preparations or restrictions for medical reasons. This is notwithstanding any preferences the
patient might have regarding special foods, such as vegetarian, kosher, etc.
|
3
|
L: (NF)
|
10387 |
NF |
no fat |
A no fat diet for acute hepatic diseases. |
3
|
L: (PAF)
|
10391 |
PAF |
phenylalanine free |
Phenylketonuria diet. |
3
|
L: (PAR)
|
10385 |
PAR |
parenteral |
Patient is supplied with parenteral nutrition, typically described in terms of i.v. medications. |
3
|
L: (RD)
|
10384 |
RD |
reduction diet |
A diet that seeks to reduce body fat, typically low energy content (800o1600 kcal.) |
3
|
L: (SCH)
|
10378 |
SCH |
schonkost (GE) |
A diet that avoids ingredients that might cause digestion problems, e.g., avoid excessive fat, avoid too much fiber (cabbage,
peas, beans.)
|
3
|
L: (T)
|
10381 |
T |
tea only |
This is not really a diet, since it contains little nutritional value, but is essentially just water. Used before coloscopy
examinations.
|
3
|
L: (VLI)
|
10392 |
VLI |
low valine, leucine, isoleucine |
Diet with low content of the amino-acids valin, leucin, and isoleucin, for "maple syrup disease." |
2
|
A: ActEncounterCode |
13955 |
|
|
Domain provides codes that qualify the ActEncounterClass (ENC) |
3
|
L: (ACUTE)
|
13956 |
ACUTE |
inpatient acute |
An acute inpatient encounter. |
3
|
L: (AMB)
|
16239 |
AMB |
ambulatory |
An ambulatory encounter. |
3
|
L: (EMER)
|
16240 |
EMER |
emergency |
An emergency encounter. |
3
|
L: (FLD)
|
16235 |
FLD |
field |
Healthcare encounter that takes place outside a healthcare facility or home (e.g., helicopter, ambulance, accident site) |
3
|
L: (HH)
|
16237 |
HH |
home health |
Healthcare encounter that takes place in the residence of the patient or a designee |
3
|
L: (NONAC)
|
16238 |
NONAC |
inpatient non-acute |
Any category of inpatient encounter except 'acute' |
3
|
L: (VR)
|
16236 |
VR |
virtual |
An interaction between a practitioner and patient (or patient's agent) where the communication does not take place in person |
2
|
A: ActIncidentCode |
16508 |
|
|
Set of codes indicating the type of incident or accident. |
3
|
L: (MVA)
|
16509 |
MVA |
Motor vehicle accident |
Incident or accident is the result of a motor vehicle accident |
3
|
L: (WPA)
|
16510 |
WPA |
Workplace accident |
Incident or accident is the result of a work place accident |
2
|
A: ActLabObsCode |
13957 |
|
|
Provides an abstract root class for laboratory observations |
3
|
A: ActLabObsArtBldCode |
14387 |
|
|
Domain provides codes that qualify the ActLabObsArtBldCode domain. (Artificial Blood) |
4
|
L: (FLUR)
|
14389 |
FLUR |
Fluorocarbons |
Refines Artificial Blood |
4
|
L: (SFHB)
|
14388 |
SFHB |
Stromal free hemoglobin preparations |
Refines Artificial Blood |
3
|
A: ActLabObsDilutionCode |
14352 |
|
|
Domain provides codes that qualify the ActLabObsDilutionCode domain. |
4
|
L: (AUTO-HIGH)
|
13958 |
AUTO-HIGH |
Auto-High Dilution |
Refines dilution |
4
|
L: (AUTO-LOW)
|
13959 |
AUTO-LOW |
Auto-Low Dilution |
Refines dilution |
4
|
L: (PRE)
|
13961 |
PRE |
Pre-Dilution |
Refines dilution |
4
|
L: (RERUN)
|
13960 |
RERUN |
Rerun Dilution |
Refines dilution |
3
|
A: ActLabObsEvnfctsCode |
14390 |
|
|
Domain provides codes that qualify the ActLabObsEnvfctsCode domain. (Environmental Factors) |
4
|
L: (A60)
|
14392 |
A60 |
Opened container, indoor atmosphere, 60 minutes du |
Refines Environmental Factors |
4
|
L: (ATM)
|
14391 |
ATM |
Opened container, atmosphere/duration unspecified |
Refines Environmental Factors |
3
|
A: ActLabObsInterferenceCode |
14382 |
|
|
Domain provides codes that qualify the ActLabObsInterferenceCode domain. |
4
|
L: (FIBRIN)
|
14386 |
FIBRIN |
Fibrin |
Refines Interference |
4
|
L: (HEMOLYSIS)
|
14383 |
HEMOLYSIS |
Hemolysis |
Refines Interference |
4
|
L: (ICTERUS)
|
14385 |
ICTERUS |
Icterus |
Refines Interference |
4
|
L: (LIPEMIA)
|
14384 |
LIPEMIA |
Lipemia |
Refines Interference |
3
|
A: ActLabObsVolumeCode |
14369 |
|
|
Domain provides codes that qualify the ActLabObsVolumeCode domain. |
4
|
L: (AVAILABLE)
|
13963 |
AVAILABLE |
Available Volume |
Refines VOLUME |
4
|
L: (CONSUMPTION)
|
13965 |
CONSUMPTION |
Consumption Volume |
Refines VOLUME |
4
|
L: (CURRENT)
|
13962 |
CURRENT |
Current Volume |
Refines VOLUME |
4
|
L: (INITIAL)
|
13964 |
INITIAL |
Initial Volume |
Refines VOLUME |
2
|
A: ActMonitoringProtocolCode |
16231 |
|
|
Identifies types of monitoring programs |
3
|
S: ControlledSubstanceMonitoringProtocol (CTLSUB)
|
16232 |
CTLSUB |
Controlled Substance |
A monitoring program that focuses on narcotics and/or commonly abused substances that are subject to legal restriction. |
2
|
A: ActPharmacySupplyType |
16208 |
|
|
Identifies types of dispensing events |
3
|
S: EmergencyPharmacySupplyType (EM)
|
16220 |
EM |
Emergency Supply |
A supply action where there is no 'valid' order for the supplied medication. E.g. Emergency vacation supply, weekend supply
(when prescriber is unavailable to provide a renewal prescription)
|
4
|
L: (SO)
|
16221 |
SO |
Script Owing |
An emergency supply where the expectation is that a formal order authorizing the supply will be provided at a later date. |
3
|
S: FirstFillPharmacySupplyType (FF)
|
16209 |
FF |
First Fill |
The initial fill against an order. (This includes initial fills against refill orders.) |
4
|
L: (FFC)
|
16210 |
FFC |
First Fill - Complete |
A first fill where the quantity supplied is equal to one full reptition of the ordered amount. (e.g. If the order was 90
tablets, 3 refills, a complete fill would be for the full 90 tablets.)
|
4
|
L: (FFP)
|
16211 |
FFP |
First Fill - Part Fill |
A first fill where the quantity supplied is less than one full reptition of the ordered amount. (e.g. If the order was 90
tablets, 3 refills, a partial fill might be for only 30 tablets.)
|
3
|
S: RefillPharmacySupplyType (RF)
|
16215 |
RF |
Refill |
A fill against an order that has already been filled (or partially filled) at least once. |
4
|
L: (RFC)
|
16216 |
RFC |
Refill - Complete |
A refill where the quantity supplied is equal to one full reptition of the ordered amount. (e.g. If the order was 90 tablets,
3 refills, a complete fill would be for the full 90 tablets.)
|
4
|
L: (RFF)
|
16218 |
RFF |
Refill (First fill this facility) |
The first fill against an order that has already been filled at least once at another facility. |
4
|
L: (RFP)
|
16217 |
RFP |
Refill - Part Fill |
A refill where the quantity supplied is less than one full reptition of the ordered amount. (e.g. If the order was 90 tablets,
3 refills, a partial fill might be for only 30 tablets.)
|
3
|
L: (DF)
|
16214 |
DF |
Daily Fill |
A fill providing sufficient supply for one day |
3
|
L: (FS)
|
16222 |
FS |
Floor stock |
A supply action to restock a smaller more local dispensary. |
3
|
L: (MS)
|
16219 |
MS |
Manufacturer Sample |
A supply of a manufacturer sample |
3
|
L: (TB)
|
16213 |
TB |
Trial Balance |
A fill where the remainder of a 'complete' fill is provided after a trial fill has been provided. |
3
|
L: (TF)
|
16212 |
TF |
Trial Fill |
A fill where a small portion is provided to allow for determination of the therapy effectiveness and patient tolerance. |
3
|
L: (UD)
|
16223 |
UD |
Unit Dose |
A supply action that provides sufficient material for a single dose. |
2
|
A: ActProcedureCode |
16535 |
|
|
The type of procedure Act |
2
|
A: ActSpecimenTreatmentCode |
14040 |
|
|
Set of codes related to specimen treatments |
3
|
L: (ACID)
|
14044 |
ACID |
Acidification |
The lowering of specimen pH through the addition of an acid |
3
|
L: (ALK)
|
14046 |
ALK |
Alkalization |
The act rendering alkaline by impregnating with an alkali; a conferring of alkaline qualities. |
3
|
L: (DEFB)
|
14043 |
DEFB |
Defibrination |
The removal of fibrin from whole blood or plasma through physical or chemical means |
3
|
L: (FILT)
|
14047 |
FILT |
Filtration |
The passage of a liquid through a filter, accomplished by gravity, pressure or vacuum (suction). |
3
|
L: (LDLP)
|
14041 |
LDLP |
LDL Precipitation |
|
3
|
L: (NEUT)
|
14045 |
NEUT |
Neutralization |
The act or process by which an acid and a base are combined in such proportions that the resulting compound is neutral. |
3
|
L: (RECA)
|
14042 |
RECA |
Recalcification |
The addition of calcium back to a specimen after it was removed by chelating agents |
3
|
L: (UFIL)
|
14048 |
UFIL |
Ultrafiltration |
The filtration of a colloidal substance through a semipermeable medium that allows only the passage of small molecules. |
2
|
A: EncounterAccomodation |
16130 |
|
|
|
3
|
L: (I)
|
16134 |
I |
isolation |
Accomodations used in the case of diseases that are transmitted through casual contact or respiratory transmission. |
3
|
L: (P)
|
16131 |
P |
private |
Accommodations in which the patient is the sole occupant. |
3
|
L: (S)
|
16133 |
S |
suite |
Uniquely designed and elegantly decorated accomodations with many amenities available for an additional charge. |
3
|
L: (SP)
|
16132 |
SP |
semi-private |
Accommodations in which the patient shares occupancy with one other patient. |
3
|
L: (W)
|
16135 |
W |
ward |
Accommodations in which more than two patients are receiving care. |
2
|
A: FinancialTransactionType |
14804 |
|
|
|
3
|
L: (CHRG)
|
14805 |
CHRG |
Standard Charge |
|
3
|
L: (REV)
|
14806 |
REV |
Standard Charge Reversal |
|
2
|
A: ReferencedCoordinateRegionType |
16117 |
|
|
Shape of the region on the object being referenced |
3
|
L: (CIRCLE)
|
16118 |
CIRCLE |
circle |
A circle defined by two (column,row) pairs. The first point is the center of the circle and the second point is a point on
the perimeter of the circle.
|
3
|
L: (ELLIPSE)
|
16119 |
ELLIPSE |
ellipse |
An ellipse defined by four (column,row) pairs, the first two points specifying the endpoints of the major axis and the second
two points specifying the endpoints of the minor axis.
|
3
|
L: (POINT)
|
16120 |
POINT |
point |
A single point denoted by a single (column,row) pair, or multiple points each denoted by a (column,row) pair. |
3
|
L: (POLY)
|
16121 |
POLY |
polyline |
A series of connected line segments with ordered vertices denoted by (column,row) pairs; if the first and last vertices are
the same, it is a closed polygon.
|
2
|
A: SubstanceAdministrationActCode |
16532 |
|
|
The specific chemical or radiological substance administered or to be administered into the body for therapeutic effect. |
3
|
A: ClinicalDrug |
16205 |
|
|
A substance or use of a substance whose therapeutic effect is produced by chemical action within the body. |
4
|
A: ManufacturedDrug |
16206 |
|
|
Identifies a drug or the use of a drug as produced by a specific manufacturer |
1
|
A: ObservationType |
16226 |
|
|
Identifies the kinds of observations that can be performed |
2
|
A: LogicalObservationIdentifierNamesAndCodes |
16492 |
|
|
The LOINC database provides a set of universal names and ID codes for identifying laboratory and clinical test results. The
purpose is to facilitate the exchange and pooling of results, such as blood hemoglobin, serum potassium, or vital signs, for
clinical care, outcomes management, and research. The LOINC codes are not intended to transmit all possible information about
a test or observation. They are only intended to identify the test result or clinical observation. http://www.regenstrief.org/LOINC/LOINC.htm
|
2
|
A: ObservationDiagnosisTypes |
16228 |
|
|
Identifies the kinds of diagnosis observations that can be performed |
2
|
L: (SEV)
|
16642 |
SEV |
Severity Observation |
Indicates a subjective evaluation of the criticality associated with another observation. |